Otello Stampacchia
Independent DirectorDr. Otello Stampacchia, Ph.D., is a Founder and Managing Director at Omega Fund Management, LLC, which he founded in 2004. He serves as a Director at Artbio Inc. He is Independent Director of Windward Bio AG and Windward Bio Group AG from January 2025. He is Director of CATALYM GmbH from July 16, 2024. He is Executive Chairman of the Board of Aerium Therapeutics. He serves as an Independent Director at ImageneBio, Inc. since July 2025. He serves as Director at Third Arc Bio, Inc. He serves as Director of Scorpion Therapeutics, Inc. since October 2020. He serves as Chief Executive Officer and Chairman of Omega Alpha Spac. He serves as Director at Amunix Pharmaceuticals, Inc. since March 2020. He serves on the Board of Directors at ArtBio GmbH. He serves as an Independent Director at Ikena Oncology, Inc. since December 2020. He serves as a Director at Amunix Operating Inc. Dr. Stampacchia focuses on oncology and inflammatory disorders. He served as Director of Rectify Pharmaceuticals, Inc. until 2025. He served as a Director of Kronos Bio, Inc. from May 2018 until March 31, 2023. He served as Board Observer of Endeavor BioMedicines, Inc. until 2022. He served as an Independent Director of Replimune Group, Inc. from May 2015 until January 2022. He served as Director of Morphic Holding, Inc. from December 2018 until April 27, 2021. He served on the Board of Directors at Nuvation Bio, Inc. from February 2019 to September 2020. He had been a Director of MEDIAN Technologies S. A. from September 29, 2014 until January 16, 2020. He was Director at ESSA Pharma Inc. from October 18, 2018 until October 17, 2019. He had been a Director of Gossamer Bio, Inc. from January 2018 to September 2019. He served as Director at Trevi Therapeutics, Inc. from July 20, 2017 until August 2018. He served as a Director of Replimune Ltd. from September 24, 2015 until July 10, 2017. He served as a Director at Paratek Pharmaceuticals, Inc. until September 2012. He served as a Director at Micromet, Inc. from May 2006 to April 16, 2010 and also served as a Member of its Supervisory Board. He was Partner and served as Head of Life Sciences at AlpInvest Partners B. V., where he was in charge of life sciences direct investments from November 2001 to December 2003. He served as the Portfolio Manager of the Lombard Odier Immunology Fund from January 2001 to November 2001. He served as a Member of the HealthCare Corporate Finance and M&A team at Goldman Sachs from 1997 to 2000. Before joining Goldman Sachs, he helped co-found the healthcare investment activities at Index Securities. He served on the boards of Directors of CropDesign NV and DeveloGen AG. He served as a Director of DrugAbuse Sciences, Inc. and BioXell S. p.A. He served as a Director of RevitalVision, LLC. He served as a Member of Supervisory Board at Intercell Ag and Evotec (Göttingen) AG. He holds a Ph. D. degree in Molecular Biology from the University of Geneva from 1992 to 1996. He also holds an MS in Plant Genetics from Universita’ degli Studi di Pavia from 1987 to 1991. He also holds a European Ph. D. in Biotechnology from the European Association for Higher Education in Biotechnology, European Union Strasbourg.
Positions
- Company NameImageneBio, Inc.Stock CodeIMAPositionIndependent DirectorColleagues
- KYKristin YaremaCEO & Director
- JJJonathan Jian WangChairman
- YGYanina Grant-HuertaCFO, Principal Financial Officer & Principal Accounting Officer
- KPKurinji PandiyanChief Strategy & Operations Officer
- RSRenuka SivendranChief Technical Officer
- MRMatt RobbinsGeneral Counsel
- DBDavid BonitaLead Independent Director
- OSOtello StampacchiaIndependent Director
- JPJoseph P. SlatteryDirector
- Company NameWindward Bio Group AGStock CodeWWBPositionIndependent DirectorColleagues
- LSLuca SantarelliCEO & Chair of the Board of Directors
- CDClaudia D'AugustaChief Financial Officer
- KAKevin Andrew HarrisChief Operating Officer
- NKNoel KurdiSenior Vice President of Investor Relations & Communications
- SAScott ApplebaumChief Legal & Corporate Development Officer
- SSSandip S. KapadiaLead Independent Director
- DBDavid BonitaIndependent Director
- IRIqbal Rasool MuftiIndependent Director
